CBAY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 Mar 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 2.02% compare to its pairs and should correct upwards.

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases...

Stats
Today's Volume	8.35M
Average Volume	3.94M
Market Cap	3.73B
EPS	$-0.370 ( Q4 \| 2024-02-28 )
Next earnings date	( $0 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-32.81 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00700 (0.02%)

AADI -3.53%

ABCL 1.83%

ABCM 0.04%

ABEO -2.13%

ABIO -1.69%

ABOS 0.00%

ABSI 1.87%

ABUS -2.13%

ABVX -2.03%

ACAD -0.58%

ACER -17.95%

ACET -5.10%

ACGN 1.29%

ACHL -2.20%

ACHV -1.29%

ACIU -1.50%

ACLX 0.25%

ACRV -5.30%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -3.93%

ADGI 0.87%

ADIL 0.54%

ADMA -2.82%

ADPT 0.30%

ADTX -3.47%

ADVM -3.40%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -0.61%

AGEN -3.03%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.95%

AKRO -2.60%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -1.15%

ALGS -2.30%

ALKS -0.23%

ALLK -8.90%

ALLO -4.71%

ALLR -3.37%

ALNA 3.16%

ALNY 2.42%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.59%

ALVR -0.40%

ALXN 0.00%

ALXO -11.19%

ALZN 1.97%

AMRN -0.72%

AMTI -3.13%

ANAB 1.05%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.75%

ANPC -3.15%

APGE -1.05%

APGN 8.48%

APGNW 30.65%

APLM -6.49%

APLS 0.50%

APLT -3.61%

APM -2.94%

APOP 0.38%

APRE 0.61%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.38%

ARDS -14.23%

ARDX -0.50%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.30%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.27%

ARWR -1.67%

ASLN -5.07%

ASMB -5.83%

ASND -1.45%

ATAI -1.48%

ATHA 5.48%

ATHE 0.55%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.67%

AUPH -0.90%

AURA 1.17%

AUTL -2.01%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.14%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.56%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.06%

BCAB 3.92%

BCDA -2.73%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 0.99%

BCTX 8.16%

BCTXW -17.41%

BCYC 1.35%

BDRX -4.94%

BDTX -0.85%

BEAM 0.82%

BFRA -2.91%

BGNE -2.99%

BIOR -3.80%

BIVI 3.85%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.25%

BMEA -11.52%

BMRN 0.52%

BNOX 4.61%

BNTC -0.42%

BNTX -1.87%

BOLD -8.58%

BOLT 0.72%

BPMC -0.99%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 25.39%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.18%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.72%

CARM 10.92%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.39%

CCCC -5.20%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.96%

CDMOP 0.04%

CDT -12.35%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.41%

CDXS 7.24%

CELC -4.55%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -1.01%

CERO -4.45%

CEROW -20.21%

CFRX -27.95%

CGEM -2.34%

CGEN -3.86%

CGON -0.83%

CGTX -4.54%

CHMA -6.00%

CHRS 0.34%

CINC 0.00%

CING 2.15%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.02%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -5.73%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -37.32%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.40%

CORT 2.02%

COYA -1.46%

CPRX -1.12%

CRBP -3.45%

CRBU -4.81%

CRDF -0.89%

CRGX 0.47%

CRIS -0.38%

CRNX -5.88%

CRSP 1.21%

CRTX 2.63%

CRVO -4.08%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.89%

CTNM -1.35%

CTXR 2.86%

CUE 3.81%

CVAC -2.54%

CVKD 0.11%

CWBR 2.80%

CYAD -12.96%

CYCC 10.09%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.78%

CYTO -1.82%

DARE 6.41%

DAWN 0.41%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.94%

DNLI -1.56%

DNTH -9.16%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.96%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.42%

EDSA 3.19%

EFTR 6.82%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.40%

ELYM 2.30%

ENGN -3.64%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.21%

ENTA -0.57%

ENTO -2.47%

ENTX 2.08%

ENVB 1.45%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.12%

EXAI -0.66%

EXEL -0.22%

EYEG -0.69%

EYEN 0.43%

EYPT 0.36%

FATE -7.53%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.77%

FENC -1.29%

FGEN -5.15%

FHTX 1.72%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.48%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.04%

FULC -3.29%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.09%

GHRS -2.16%

GLMD -4.96%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.51%

GLYC -9.52%

GMAB -0.58%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.91%

GNLX 1.11%

GNPX 0.98%

GNTA 3.94%

GOSS -12.01%

GOVX 5.00%

GOVXW -49.04%

GPCR -6.78%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.36%

GRTX 2.57%

GTHX 1.14%

GUTS -5.54%

GXGXW 41.67%

GYRE -6.02%

HALO -1.49%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK -0.76%

HOTH -2.70%

HOWL -2.77%

HRMY 0.37%

HRTX 3.77%

HSTO 0.00%

HUMA 0.61%

HUMAW -0.01%

IBRX -4.06%

ICCC 0.22%

ICPT 0.21%

ICU 17.27%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.72%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB -0.29%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 5.70%

IMMX -7.33%

IMNM -1.82%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.70%

INAB -0.01%

INBX 0.43%

INCY -0.94%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.36%

INMB 2.44%

INO -2.20%

INSM -1.23%

INTS -2.75%

INVA 0.34%

INZY 1.03%

IOBT -11.81%

IONS 0.21%

IOVA -2.13%

IPA 2.50%

IPHA 5.58%

IPSC -1.95%

IRON -2.43%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 1.45%

JANX -4.05%

JAZZ -0.69%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.73%

KDNY 0.22%

KMPH -0.34%

KNSA -2.64%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.38%

KRBP -10.00%

KRON 1.05%

KROS -1.38%

KRRO -8.23%

KRTX 0.03%

KRYS -1.16%

KTRA 16.00%

KTTA 8.16%

KTTAW 0.92%

KURA -1.51%

KYMR -2.60%

KYTX -4.13%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.11%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.91%

LENZ -3.84%

LEXX 1.16%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.80%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.95%

LPTX -1.65%

LQDA -0.90%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -2.06%

LYEL -33.41%

LYRA 0.93%

MACK 0.10%

MBIO -11.28%

MBRX -2.57%

MCRB 2.43%

MDGL -3.53%

MDNA -13.16%

MDWD 0.03%

MDXG -2.58%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.56%

MGX -4.83%

MIRM -1.60%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.89%

MLYS -6.49%

MNKD -1.05%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.20%

MORF -2.75%

MREO -3.71%

MRKR 2.68%

MRNA -5.18%

MRNS -4.41%

MRSN -1.90%

MRTX -0.17%

MRUS 0.25%

MRVI -1.89%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.93%

NKGN 8.33%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.89%

NLSP 7.65%

NLSPW 26.67%

NMRA -3.20%

NMTR -42.97%

NOVN -24.84%

NRBO 12.63%

NRIX -0.31%

NRSN -5.18%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.63%

NTRBW -31.07%

NUVL -1.53%

NVAX -2.43%

NVCT 2.39%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -3.36%

OBSV 0.00%

OCEA -0.70%

OCGN 3.81%

OCS -1.00%

OCUL -1.83%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.39%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -3.41%

ORMP 20.98%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.29%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -4.89%

PBYI 1.35%

PCSA 0.00%

PCVX -0.34%

PDSB -3.52%

PEPG 2.56%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -0.85%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.20%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -10.64%

PRAX 1.04%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.60%

PRTA -2.26%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -6.18%

PSTX -0.58%

PTCT -0.74%

PTE -0.82%

PTGX -1.39%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.63%

QLGN -8.10%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.83%

QURE -0.84%

RAIN -1.63%

RANI 6.42%

RAPT -3.57%

RARE 1.33%

RCKT -7.80%

REGN -0.26%

RENB -3.42%

REPL -2.83%

RETA 0.02%

REUN -0.89%

REVB -1.42%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.93%

RIGL -3.28%

RLAY -3.78%

RLMD 0.33%

RLYB -0.67%

RNA 0.03%

RNAC -5.94%

RNAZ -0.96%

RNXT 1.88%

ROIV -1.99%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.24%

RPTX -3.20%

RUBY 2.70%

RVLP -32.05%

RVMD -0.93%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.34%

RYZB 0.02%

RZLT 1.55%

SABS -1.37%

SABSW -11.81%

SAGE 2.02%

SANA -3.87%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.23%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -6.41%

SLGL 2.97%

SLN -4.40%

SLNO -3.84%

SLRX 6.07%

SLS -2.14%

SMMT -2.62%

SNDX 1.51%

SNGX -2.66%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.13%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -4.86%

STRO -2.85%

STSA 0.00%

STTK -1.55%

SURF -0.93%

SVRA -4.87%

SWTX 0.19%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.56%

TBPH 0.60%

TCBP 2.47%

TCDA 0.00%

TCON 2.74%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.11%

TENX -1.27%

TERN -7.45%

TFFP -5.33%

TGTX -3.18%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -6.19%

TNYA -5.43%

TPST 2.98%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.75%

TSVT -2.93%

TTNP -7.79%

TVTX 0.88%

TYRA -7.13%

UBX -0.71%

UNCY -3.90%

URGN -1.52%

UTHR -0.48%

VACC 11.36%

VALN -2.89%

VAXX 83.69%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -0.93%

VERA -3.86%

VERU -0.72%

VERV -2.87%

VIGL 7.26%

VINC 2.96%

VIR 0.65%

VIRI -1.61%

VIRX 2.40%

VKTX -1.26%

VLON -13.04%

VNDA -2.61%

VOR -2.02%

VRCA 0.00%

VRDN -4.23%

VRNA -1.40%

VRPX 0.38%

VRTX 0.29%

VSTM -1.19%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.72%

VYGR -0.77%

VYNE -4.60%

VYNT 7.78%

WINT -3.24%

WVE -4.19%

XBIO 0.93%

XBIT -1.04%

XCUR 3.58%

XENE -2.86%

XERS 2.14%

XFOR 2.86%

XLO 4.54%

XLRN 0.00%

XNCR 0.47%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.96%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.89%

ZNTL -0.69%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-22	Loewy Caroline M	Sell	30 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	15 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	7 500	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	16 000	Employee Stock Option (right to buy)
2024-03-22	Loewy Caroline M	Sell	27 705	Employee Stock Option (right to buy)

INSIDER POWER
-97.48
Last 100 transactions
Buy: 127 470 \| Sell: 9 848 383

Correlation (AI algo v.1.1b): Undervalued: 2.02% $33.13 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.17 (neutral)

Short: -0.63 (weak negative)

Signal:(46.979) Neutral

Cymabay Therapeutics Inc Correlation

10 Most Positive Correlations
DWACU	0.879
DWAC	0.859

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cymabay Therapeutics Inc Correlation - Currency/Commodity

0.25
( neutral )

0.00
( neutral )

0.41
( neutral )

Cymabay Therapeutics Inc Financials

Annual	2023
Revenue:	$31.07M
Gross Profit:	$30.39M (97.81 %)
EPS:	$-0.990

FY	2023
Revenue:	$31.07M
Gross Profit:	$30.39M (97.81 %)
EPS:	$-0.990

FY	2022
Revenue:	$0
Gross Profit:	$-710 000 (0.00 %)
EPS:	$-1.350

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.304

Financial Reports:

No articles found.

Cymabay Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cymabay Therapeutics Inc

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.